Vor Biopharma VOR CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's capex?
- Vor Biopharma (VOR) reported capex of $48K in Q1 2026.
- How has Vor Biopharma's capex changed year-over-year?
- Vor Biopharma's capex decreased by 79.2% year-over-year, from $231K to $48K.
- What is the long-term trend for Vor Biopharma's capex?
- Over 4 years (2021 to 2025), Vor Biopharma's capex has grown at a -29.9% compound annual growth rate (CAGR), from $3.89M to $941K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.